Biotech · Private company
Biohaven Therapeutics Ltd.
Track this companyFree. Adds Biohaven Therapeutics Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials1811 recruiting or active
Pipeline programs15From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline15
- BHV-1300Phase 3 · Graves DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- BHV-7000Phase 3 · Bipolar DisorderClinicalTrials.gov · fetched Nov 12, 2026
- BHV-7000Phase 3 · Generalized EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- BHV-7000Phase 3 · Focal EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- BHV-8000 10mgPhase 3 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- BHV-8000 20 mgPhase 3 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- BHV-1510Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- BHV-2100Phase 2 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- BHV-7000Phase 2 · Major Depressive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- CemiplimabPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Taldefgrobep AlfaPhase 2 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
- BHV-1400Phase 1 · IgA NephropathyClinicalTrials.gov · fetched Nov 12, 2026
- BHV-1530Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- BHV-7000Phase 1 · Familial ErythromelalgiaClinicalTrials.gov · fetched Nov 12, 2026
- BHV-4157Spinocerebellar AtaxiasClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials18
- Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' DiseasePHASE3 · RECRUITING · started Jun 26, 2026ClinicalTrials.gov NCT07661056 · fetched Nov 12, 2026
- A Phase 1b Study of BHV-7000 in Participants With Inherited ErythromelalgiaPHASE1 · ACTIVE_NOT_RECRUITING · started Jan 15, 2026ClinicalTrials.gov NCT07262268 · fetched Nov 12, 2026
- Taldefgrobep Alfa in Adults With Overweight and ObesityPHASE2 · ACTIVE_NOT_RECRUITING · started Nov 24, 2025ClinicalTrials.gov NCT07281495 · fetched Nov 12, 2026
- Study of BHV-1300 in Graves' DiseasePHASE1 · RECRUITING · started Aug 21, 2025ClinicalTrials.gov NCT06980649 · fetched Nov 12, 2026
- Study of BHV-1400 in IgA NephropathyPHASE1 · RECRUITING · started Jul 30, 2025ClinicalTrials.gov NCT07054684 · fetched Nov 12, 2026
- A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseasePHASE2_PHASE3 · RECRUITING · started May 28, 2025ClinicalTrials.gov NCT06976268 · fetched Nov 12, 2026
- A Phase 1 Study of BHV-1530 in Advanced Solid TumorsPHASE1 · RECRUITING · started Mar 20, 2025ClinicalTrials.gov NCT06874335 · fetched Nov 12, 2026
- Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of MigrainePHASE2 · COMPLETED · started Oct 10, 2024ClinicalTrials.gov NCT06603623 · fetched Nov 12, 2026
- Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)PHASE2 · COMPLETED · started Aug 1, 2024ClinicalTrials.gov NCT06423781 · fetched Nov 12, 2026
- Long-term Safety and Tolerability of BHV-7000PHASE2 · ENROLLING_BY_INVITATION · started Jul 30, 2024ClinicalTrials.gov NCT06443463 · fetched Nov 12, 2026
- BHV-7000 Open-Label Extension Bipolar Mania StudyPHASE2 · TERMINATED · started Jun 24, 2024ClinicalTrials.gov NCT06423794 · fetched Nov 12, 2026
- A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic SeizuresPHASE2_PHASE3 · TERMINATED · started Jun 20, 2024ClinicalTrials.gov NCT06425159 · fetched Nov 12, 2026
- Efficacy and Safety Study of BHV-7000 Monotherapy in Major DepressionPHASE2 · COMPLETED · started May 28, 2024ClinicalTrials.gov NCT06419608 · fetched Nov 12, 2026
- BHV-7000 Acute Treatment of Bipolar ManiaPHASE2_PHASE3 · COMPLETED · started May 28, 2024ClinicalTrials.gov NCT06419582 · fetched Nov 12, 2026
- Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset EpilepsyPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started May 13, 2024ClinicalTrials.gov NCT06309966 · fetched Nov 12, 2026
- A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Apr 22, 2024ClinicalTrials.gov NCT06384807 · fetched Nov 12, 2026
- A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset EpilepsyPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Mar 14, 2024ClinicalTrials.gov NCT06132893 · fetched Nov 12, 2026
- Real-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA) Compared to a Matched Natural History ControlCOMPLETED · started Mar 18, 2019ClinicalTrials.gov NCT06529146 · fetched Nov 12, 2026